Kazuo Izumi
-
- Diabetes Management and Research 13
- Diabetes Management and Education 12
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
- Diabetes Treatment and Management 7
-
- Chronic Disease Management Strategies 9
-
- Dialysis and Renal Disease Management 5
-
- Peripheral Artery Disease Management 4
-
- Mobile Health and mHealth Applications 4
- Co-authors
- Mitsuhiko NodaYasuaki HayashinoHiroshi YuasaNobutaka TakahashiAkira SakuraiMasatomo KobayashiSachiko NakagawaHideki Origasa
- Journals
- Journal of Biological Chemistry (1 paper)Scientific Reports (1 paper)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Kazuo Izumi
56 papers receiving 822 citations
Peers
Comparison fields: 5 of 121
- Endocrinology, Diabetes and Metabolism 201
- Molecular Biology 304
- Plant Science 161
- Cell Biology 69
- Neurology 64
Countries citing papers authored by Kazuo Izumi
This map shows the geographic impact of Kazuo Izumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Izumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Izumi more than expected).
Fields of papers citing papers by Kazuo Izumi
This network shows the impact of papers produced by Kazuo Izumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Izumi. The network helps show where Kazuo Izumi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kazuo Izumi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 7 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 4 | |
| 10 | 2019 | 7 | |
| 11 | 2018 | 0 | |
| 12 | 2016 | 28 | |
| 13 | 2015 | 35 | |
| 14 | 2013 | 7 | |
| 15 | 2009 | 0 | |
| 16 | 2000 | 8 | |
| 17 | 1997 | 27 | |
| 18 | The development of uniconazole as a new plant growth retardant and studies on its mechanism of action and practical uses. | 1990 | 6 |
| 19 | Colchicine-like effect of propyzamide on the root meristematic cells of Vicia faba L | 1983 | 2 |
| 20 | Two Primary Melanomas of the Human Brain | 1979 | 2 |
About Kazuo Izumi
Kazuo Izumi is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Biotechnology, having authored 64 papers that have together received 861 indexed citations. Recurring topics across this work include Diabetes Management and Research (13 papers), Diabetes Management and Education (12 papers), Chronic Disease Management Strategies (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Diabetes Treatment and Management (7 papers), Dialysis and Renal Disease Management (5 papers), Peripheral Artery Disease Management (4 papers) and Mobile Health and mHealth Applications (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (201 citations), Molecular Biology (304 citations) and Plant Science (161 citations). Kazuo Izumi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Mitsuhiko Noda, Yasuaki Hayashino, Hiroshi Yuasa, Nobutaka Takahashi, Akira Sakurai, Masatomo Kobayashi, Sachiko Nakagawa, Hideki Origasa, Naoko Tajima and Rimei Nishimura. Their work appears in journals such as Journal of Biological Chemistry, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.